Literature DB >> 31389291

Metacognition in functional cognitive disorder- a potential mechanism and treatment target.

Rohan Bhome1, Andrew McWilliams2,3,4, Jonathan D Huntley1, Stephen M Fleming3,5, Robert J Howard1.   

Abstract

Introduction: Functional Cognitive Disorder (FCD) is common. Despite this, there is no evidence-based consensus on how to treat FCD. Poor metacognitive ability has been suggested as a key mechanism underlying the disorder. This paper evaluates the proposal that strategies which improve metacognition could provide a mechanistically plausible translational therapy.
Methods: We reviewed the existing literature relating to metacognition in FCD, previous strategies to improve metacognitive ability in FCD and whether metacognitive performance can be modulated.
Results: Though limited, there is evidence to suggest that metacognition is impaired in FCD. Converging evidence from neuroimaging studies suggests that metacognitive performance can be modulated. The effectiveness of existing strategies to improve metacognition including cognitive training, psychoeducation and lifestyle interventions have been equivocal. Recently, a potential treatment option has emerged in the form of a computer-based metacognitive training paradigm. Conclusions: There is an urgent need for effective treatments in FCD. Impaired metacognition may be a plausible therapeutic target but, in the first instance, further research is required to demonstrate deficits in "local" metacognitive ability in FCD patients when measured objectively. If so, clinical trials of interventions, such as computerised metacognitive training, are required to evaluate their effectiveness in improving FCD symptoms.

Entities:  

Keywords:  Functional cognitive disorder; mechanism; metacognition; treatment

Mesh:

Year:  2019        PMID: 31389291     DOI: 10.1080/13546805.2019.1651708

Source DB:  PubMed          Journal:  Cogn Neuropsychiatry        ISSN: 1354-6805            Impact factor:   1.871


  6 in total

Review 1.  Functional neurological disorder: new subtypes and shared mechanisms.

Authors:  Mark Hallett; Selma Aybek; Barbara A Dworetzky; Laura McWhirter; Jeffrey P Staab; Jon Stone
Journal:  Lancet Neurol       Date:  2022-04-14       Impact factor: 59.935

Review 2.  The Scope of Metacognitive Therapy in the Treatment of Psychiatric Disorders.

Authors:  Vandita Sharma; Rajesh Sagar; Gaurishanker Kaloiya; Manju Mehta
Journal:  Cureus       Date:  2022-03-23

3.  Metacognition in functional cognitive disorder: contradictory or convergent experimental results?

Authors:  A J Larner
Journal:  Brain Commun       Date:  2022-05-27

4.  Metacognition in functional cognitive disorder.

Authors:  Rohan Bhome; Andrew McWilliams; Gary Price; Norman A Poole; Robert J Howard; Stephen M Fleming; Jonathan D Huntley
Journal:  Brain Commun       Date:  2022-02-22

5.  Mobile facial affect recognition and real-time social experiences in serious mental illness.

Authors:  Emma M Parrish; Jiayi Lin; Vanessa Scott; Amy E Pinkham; Philip D Harvey; Raeanne C Moore; Robert Ackerman; Colin A Depp
Journal:  Schizophr Res Cogn       Date:  2022-04-08

Review 6.  Functional cognitive disorder: dementia's blind spot.

Authors:  Harriet A Ball; Laura McWhirter; Clive Ballard; Rohan Bhome; Daniel J Blackburn; Mark J Edwards; Stephen M Fleming; Nick C Fox; Robert Howard; Jonathan Huntley; Jeremy D Isaacs; Andrew J Larner; Timothy R Nicholson; Catherine M Pennington; Norman Poole; Gary Price; Jason P Price; Markus Reuber; Craig Ritchie; Martin N Rossor; Jonathan M Schott; Tiago Teodoro; Annalena Venneri; Jon Stone; Alan J Carson
Journal:  Brain       Date:  2020-10-01       Impact factor: 13.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.